Taking part in research

Research

Lecanemab made headlines as the first MHRA-approved drug in the UK to slow early-stage Alzheimer’s disease, but it has not been recommended for use on the NHS. Here is what we know so far about this breakthrough Alzheimer's drug. 

Research

Getting an early and accurate dementia diagnosis will only become more important as new treatments become available, so research into this area is vital.

Research

Important as they are, drugs and technology aren’t the only ways to make a difference for people living with dementia – could you help?

Research

Hear from volunteers helping to research new technology which could enable people with dementia to remain independent for longer.